Stay updated on Bumetanide Oral Liquid in ASD Children Clinical Trial
Sign up to get notified when there's something new on the Bumetanide Oral Liquid in ASD Children Clinical Trial page.

Latest updates to the Bumetanide Oral Liquid in ASD Children Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study record. A Home link is shown, indicating the resource is temporarily unavailable or access-restricted.SummaryDifference19%

- Check17 days agoChange DetectedAdded a new revision label v3.7.0 replacing the previous v3.6.6 in the study record. This reflects an update to the page's versioning metadata rather than substantive changes to the study details.SummaryDifference0.0%

- Check31 days agoChange DetectedRevision number on the page updated from v3.6.5 to v3.6.6, indicating a software update to the site. There is no indication of changes to study content or data in this update.SummaryDifference0.0%

- Check38 days agoChange DetectedA new NIH funding reference (2017) was added to the study's identifiers, indicating funding information associated with the trial.SummaryDifference0.0%

- Check52 days agoChange DetectedRevision label updated from v3.6.4 to v3.6.5, indicating a software version change on the page. The underlying study information remains unchanged and this is a technical UI update.SummaryDifference0.0%

- Check66 days agoChange DetectedThe page's revision tag was updated from v3.6.3 to v3.6.4, indicating a software update to the site. This update is behind the scenes and does not modify the displayed study details.SummaryDifference0.0%

Stay in the know with updates to Bumetanide Oral Liquid in ASD Children Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Bumetanide Oral Liquid in ASD Children Clinical Trial page.